Skip to content

LNP Summit 2025: Precision Nanomedicine for Targeted Drug Delivery

Presented at our LNP Summit Boston – Sept 9, 2025
by Dr. Dr. Daniel Heller, Head, Cancer Nanomedicine Laboratory, Sloan Kettering Institute

Dr. Daniel Heller shares innovative formulation approaches aimed at improving nanoparticle delivery to different organs and tumor micro‑environments. He highlights:

🔹 One of the field’s biggest challenges: crossing the blood–brain barrier

🔹 How his team is developing nanoparticles capable of penetrating this barrier to reach brain tumors and other neurological diseases

 

Access LNP Video Now

Want to find out more?

Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.